Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Rizatriptan goes head-to-head with sumatriptan in migraine patients

Dec. 17, 1996

Cortex notified of broad patent covering calpain inhibitors

Dec. 17, 1996

Acea describes candidate neuroprotectant

Dec. 16, 1996

Neurogen and Pfizer extend GABA-based collaboration

Dec. 16, 1996

Eisai describes selective dopamine D3 antagonists

Dec. 16, 1996

DuPont Merck evaluates new candidate cognition enhancer

Dec. 13, 1996

Therapeutically active cysteine proteinase inhibitors described by Synphar

Dec. 13, 1996

NMDA antagonists ameliorate ototoxicity of aminoglycoside antibiotics

Dec. 12, 1996

Janssen files for lower-dose risperidone in U.S.

Dec. 12, 1996

New antidepressant compounds in development at HMR

Dec. 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...